ARYx Therapeutics, Inc. (ARYX)
Develops oral medications for blood clots, heart rhythm disorders, and digestive problems.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
ARYX is trading near its 52-week highs and above both its 50- and 200-day moving averages, showing strong recent price momentum. Analyst coverage appears minimal or unavailable for this micro-cap stock. The current data reflects elevated positioning within its annual range, though liquidity and volatility at this price level warrant caution for casual investors.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$16,730
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—